Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Tate & Lyle launches new isotonic sports drink solution
Company is launching a new sweetening solution for isotonic sports drinks for the European market – Sports Drink REBALANCE(TM) 015.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Encouraging Results for Folic Acid for Cancer Prevention
Small study in CANCER indicates finds that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Functional Foods & Nutraceuticals launches Digital Edition
Functional Foods & Nutraceuticals (“FF&N”), a publication of New Hope Natural Media, announced the global expansion of FF&N’s digital edition.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Bayer Pharma Signs Agreement with Vitiva
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration, based on exclusive isolation of esters from marigold flower, with Bayer Pharma has registering a patent for a natural OTC product worldwide based on marigold flower extracts.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Adrian Lindridge Named European Sales Director
MISSOULA, Mont. (June 14, 2006) – TSI Health Sciences, a leading developer, producer and marketer of nutraceutical and pharmaceutical ingredients, today announced the opening of its first sales and marketing office in Europe. Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
“Demand for high quality nutraceutical ingredients in Europe has steadily increased over the past few years,” said Larry Kolb, TSI Health Sciences president, U.S. operations. “TSI has established a presence in this market and we’ve realized we needed an office in Europe to build upon our momentum. This office will allow us to better serve our existing clients and increase our customer base.”
Lindridge will be responsible for creating and implementing comprehensive sales and marketing strategies to educate European customers on the company and its extensive product lines. Prior to joining TSI, Lindridge worked for SSL International plc, a global consumer healthcare company. During his 18 years of employment with SSL, Lindridge held many positions, including head of the OTC business development, director of UK consumer marketing and marketing manager, Europe. Lindridge has an MBA from University of Bradford and a bachelor’s degree in physiology from University of Leeds.
About TSI Health Sciences
TSI Health Sciences, www.tsiinc.com, has evolved throughout the last decade to focus primarily on in-house, high-end ingredient production and has become a leading developer, producer and marketer of nutraceutical ingredients to the dietary supplement, pharmaceutical and food and beverage industries. With US operations based in Missoula, Mont., TSI was founded in 1996 and has offices worldwide, including a 60-acre, fully integrated manufacturing, research, quality assurance and quality control campus in Jiangyin, China. The company’s comprehensive product range includes botanical, marine and natural product extracts, as well as synthesized compounds. TSI guarantees full-service cGMP manufacturing through TSI Manufacturing Systems, with divisions specializing in small and large-scale botanical and natural product extraction, large-scale chemical synthesis production and secondary processing capabilities.
# # # |